OKYO Pharma Limited announces that it has applied to the UK Financial Conduct Authority and London Stock Exchange plc to effect a cancellation of its ordinary shares of no par value each from listing on the standard segment of the FCA’s Official List and trading on the main market for listed securities of the LSE […]
Notice of Intention to Delist From The London Stock Exchange Read More »
Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announced that three German-based companies have selected ColoAlert®, the Company’s highly efficacious and easy-to-use screening test for colorectal cancer into their respective corporate health programs.
BioArctic AB announced that its partner Eisai has published an article about long-term health outcomes of anti-amyloid-beta protofibril[1] antibody lecanemab in people living with mild cognitive impairment due to Alzheimer’s disease and mild AD using a disease simulation model in the peer-reviewed journal Neurology and Therapy.
iNtRON Biotechnology has announced that iNtRON has demonstrated the effectiveness of P18-BE3CRC using a cancer organoid model.
Spago Nanomedical Hans Arwidsson is proposed as new chairman of the board and Alan Raffensperger is proposed as new board member.
Biovica International Biovica, active in cancer monitoring, announces that the company has signed a commercial partnership agreement with the Italian company, IT Health Fusion, for the commercialization of the DiviTum® TKa assay in Italy.
Biovica establishes DiviTum(R) TKa Commercialization Partnership in Italy Read More »
Beactica Therapeutics AB, the Swedish precision oncology company, and Oscotec Inc., the Korean drug development company, announced that they have mutually agreed to terminate their collaboration and licensing agreement.
Beactica Therapeutics and Oscotec mutually agree to conclude oncology collaboration Read More »
RELIEF THERAPEUTICS Holding SA announced it has called an extraordinary general meeting of shareholders to be held at 10:00 a.m. CEST on Friday, April 28, 2023 in Geneva.
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders Read More »
La prevalencia de sentimientos de angustia emocional aumentó del 25 al 31 % entre 2009 y 2021
Amar Desai is back at UnitedHealth as senior adviser to its CEO Andrew Witty.
UnitedHealth executive returns to company 6 months after leaving for CVS Read More »
